Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Elisa Boni

Showing results (11-20 of 30) with videos related to

Pageof 3
Sort By:
Plos One|July 8, 2017
Which immunotherapy product is better for patients allergic to Polistes venom? A laboratory and clinical studyEleonora Savi, Cristoforo Incorvaia, Elisa Boni, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 2022
A comprehensive molecular approach in fish allergy: Usefulness in daily clinical practiceDanilo Villalta, Enrico Scala, Gaia Deleonardi, et al.
Allergy|May 16, 2023
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentGunter Johannes Sturm, Elisa Boni, Darío Antolín-Amérigo, et al.
International Journal of Dermatology|June 16, 2011
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma SyndromeGiovanni Ponti, Gabriele Luppi, Lorena Losi, et al.
Allergy|October 11, 2025
The Sting Challenge Test: An EAACI Position Paper on Hymenoptera Venom AllergyArantza Vega Castro, Christine Breynaert, Teresa Alfaya, et al.
Oncology Reports|January 1, 2010
Gastrointestinal stromal tumor and other primary metachronous or synchronous neoplasms as a suspicion criterion for syndromic settingGiovanni Ponti, Gabriele Luppi, Davide Martorana, et al.
Annals of Intensive Care|April 23, 2020
Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patientsIlaria Godi, Silvia De Rosa, Francesca Martino, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2017
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be SuspectedPatrizia Bonadonna, Roberta Zanotti, Mauro Pagani, et al.
Minerva Anestesiologica|June 16, 2022
Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trialLuca Tabbì, Roberto Tonelli, Vittoria Comellini, et al.
International Journal of Molecular Sciences|October 16, 2025
Gender and Allergy: Mechanisms, Clinical Phenotypes, and Therapeutic Response-A Position Paper from the Società Italiana di Allergologia, Asma ed Immunologia Clinica (SIAAIC)Maria Teresa Ventura, Antonio Francesco Maria Giuliano, Elisa Boni, et al.
Pageof 3

Showing results (11-20 of 30) with videos related to

Sort By:
Pageof 3
Plos One|July 8, 2017
Which immunotherapy product is better for patients allergic to Polistes venom? A laboratory and clinical studyEleonora Savi, Cristoforo Incorvaia, Elisa Boni, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|June 18, 2022
A comprehensive molecular approach in fish allergy: Usefulness in daily clinical practiceDanilo Villalta, Enrico Scala, Gaia Deleonardi, et al.
Allergy|May 16, 2023
Allergy to stings and bites from rare or locally important arthropods: Worldwide distribution, available diagnostics and treatmentGunter Johannes Sturm, Elisa Boni, Darío Antolín-Amérigo, et al.
International Journal of Dermatology|June 16, 2011
p16 immunohistochemistry of multiple primary melanomas as screening to identify Familial Melanoma SyndromeGiovanni Ponti, Gabriele Luppi, Lorena Losi, et al.
Allergy|October 11, 2025
The Sting Challenge Test: An EAACI Position Paper on Hymenoptera Venom AllergyArantza Vega Castro, Christine Breynaert, Teresa Alfaya, et al.
Oncology Reports|January 1, 2010
Gastrointestinal stromal tumor and other primary metachronous or synchronous neoplasms as a suspicion criterion for syndromic settingGiovanni Ponti, Gabriele Luppi, Davide Martorana, et al.
Annals of Intensive Care|April 23, 2020
Urinary [TIMP-2] × [IGFBP7] and serum procalcitonin to predict and assess the risk for short-term outcomes in septic and non-septic critically ill patientsIlaria Godi, Silvia De Rosa, Francesca Martino, et al.
The Journal of Allergy and Clinical Immunology. in Practice|December 21, 2017
Anaphylactic Reactions After Discontinuation of Hymenoptera Venom Immunotherapy: A Clonal Mast Cell Disorder Should Be SuspectedPatrizia Bonadonna, Roberta Zanotti, Mauro Pagani, et al.
Minerva Anestesiologica|June 16, 2022
Delirium incidence and risk factors in patients undergoing non-invasive ventilation for acute respiratory failure: a multicenter observational trialLuca Tabbì, Roberto Tonelli, Vittoria Comellini, et al.
International Journal of Molecular Sciences|October 16, 2025
Gender and Allergy: Mechanisms, Clinical Phenotypes, and Therapeutic Response-A Position Paper from the Società Italiana di Allergologia, Asma ed Immunologia Clinica (SIAAIC)Maria Teresa Ventura, Antonio Francesco Maria Giuliano, Elisa Boni, et al.
Pageof 3